Trump Meets With Pharma Execs, but Jim Cramer Still Isn't Hot on the Sector

Jim Cramer still isn't a fan of drug stocks.
Publish date:

TheStreet's Jim Cramer says he's still sees no reason to jump into pharmaceutical stocks, even after President Trump meets with CEOs of big drug companies. Cramer says there's limited upside for the group.